Two Sigma Securities’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-84,500
Closed -$5.65M – 2631
2024
Q3
$5.65M Buy
84,500
+37,000
+78% +$3.4M 0.1% 255
2024
Q2
$5.64M Sell
47,500
-28,300
-37% -$3.58M 0.07% 324
2024
Q1
$8.08M Buy
75,800
+3,300
+5% +$333K 0.08% 273
2023
Q4
$7.21M Buy
72,500
+25,000
+53% +$2.1M 0.07% 276
2023
Q3
$4.91M Sell
47,500
-87,000
-65% -$9.7M 0.05% 368
2023
Q2
$16.3M Buy
134,500
+72,900
+118% +$9.7M 0.24% 83
2023
Q1
$9.46M Buy
61,600
+44,100
+252% +$7.28M 0.19% 110
2022
Q4
$3.14M Sell
17,500
-106,700
-86% -$17.4M 0.09% 272
2022
Q3
$14.7M Sell
124,200
-41,100
-25% -$6.24M 0.44% 32
2022
Q2
$23.6M Buy
165,300
+104,000
+170% +$14.9M 0.84% 7
2022
Q1
$10.6M Buy
61,300
+58,200
+1,877% +$9.8M 0.37% 33
2021
Q4
$787K Sell
3,100
-11,900
-79% -$3.48M 0.03% 340
2021
Q3
$5.77M Buy
15,000
+2,400
+19% +$885K 0.17% 94
2021
Q2
$2.96M Buy
+12,600
New +$2.25M 0.09% 163
2021
Q1
– Sell
-3,800
Closed -$397K – 1425
2020
Q4
$397K Buy
+3,800
New +$384K 0.01% 841

Other funds holding MRNA

Two Sigma Securities's MRNA Position: Q3 2026 in Review

Two Sigma Securities opened a new position in Moderna (MRNA) in Q3 2026: 8,606 shares worth $1.66M. The stake represents 0.13% of the portfolio and ranks #168 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in MRNA as recently as Q3 2023.

Two Sigma Securities first reported a position in MRNA in Q4 2020 and has held it in 13 quarters since. The position peaked at $7.74M in Q1 2023. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Two Sigma Securities held 8,606 shares of Moderna worth $1.66M as of Q3 2026.
  • Moderna was a new Two Sigma Securities position in Q3 2026.
  • Moderna made up 0.13% of Two Sigma Securities's portfolio in Q3 2026, its #168 holding.
  • Two Sigma Securities first reported a position in Moderna in Q4 2020 and has held it in 13 quarters since.
  • Two Sigma Securities's Moderna position peaked at $7.74M in Q1 2023.
  • 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.